MedPath
FDA Approval

Ustell

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 10, 2017
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Hexamethylenetetramine(120 mg in 1 1)
Phenyl salicylate(36 mg in 1 1)
Methylene blue(10 mg in 1 1)
Hyoscyamine(0.12 mg in 1 1)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ustell

Product Details

NDC Product Code
0076-0903
Route of Administration
ORAL
Effective Date
January 10, 2017
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
AMMONIAInactive
Code: 5138Q19F1XClass: IACT
ANHYDROUS DIBASIC CALCIUM PHOSPHATEInactive
Code: L11K75P92JClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
SHELLACInactive
Code: 46N107B71OClass: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65APClass: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JPClass: IACT
Code: J50OIX95QVClass: ACTIBQuantity: 120 mg in 1 1
Code: 593YOG76RNClass: ACTIBQuantity: 40.8 mg in 1 1
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4Class: IACT
Code: 28A37T47QOClass: ACTIBQuantity: 36 mg in 1 1
Code: T42P99266KClass: ACTIBQuantity: 10 mg in 1 1
Code: F2R8V82B84Class: ACTIBQuantity: 0.12 mg in 1 1

Drug Labeling Information

Complete FDA-approved labeling information including indications, dosage, warnings, contraindications, and other essential prescribing details.

WARNINGS SECTION

WARNINGS

Do not exceed recommended dosage. If rapid pulse, dizziness or blurring of vision occurs discontinue use immediately.


© Copyright 2025. All Rights Reserved by MedPath